New Drug Therapy In The Treatment Of Aids, Cancer

NameProfessorSubjectDecember 4 , 2007New Drug Therapy in the Treatment of help and CancerIntroductionThere atomic number 18 umteen recent do drugs therapies usable in the other hospitals and clinic today . By providing drug therapies on AIDS and crabby personous neoplastic sickness longanimouss and its familiesa would have much hope on the retrieval of the patient s strength . However , not exclusively new drug therapies were sanctioned by FDA and WHO . There are signifi shadowt processes that were conducted in the beginning these therapies will completely beseem part of the medical healing(predicate) industry . This will encompass the twain different new found therapy intercessions for Aids and cancer - Ixempra (Ixapebilone ) for cancer and Antiretrovival therapy for AIDS /human immunodeficiency virus . Through the discussion of these two therapies , we could be able to larn the situations and posture of these therapies to the two of the intimately sensitive illnesses in the worldThe IxabepiloneThe Ixapeboline was created for heart cancer cases . It provides therapy in replacement to the usual chemotherapy that was made during the interposition of detractor cancer . This intervention was s last June to avail mamilla cancer patients in their illness in a more(prenominal) advanced and expert way . After quartet month of review , the FDA approved this therapy and would be readily available to the concerned patients as briefly as possibleIxabepilone , which will be marketed under the brand seduce Ixempra , is indicated for use in cabal with capecitabine in patients who no longer benefit from chemotherapy with anthracyclines (such as doxorubicin or epirubicin ) and taxanes (such as paclitaxel or docetaxel . It can also be apply alone in patients who no longer benefit from an anth racycline , a taxane and capecitabine ? -tub! ulin subunit in concomitant , but is structurally quite different to the taxanes .

Ixabepilone is an analogue of epothilone B , which means that it is more cheerful for the patients having mammilla cancer because it is more radical than the chemotherapy procedure that was make before Its content provides more active elements that would help debar the cyst within the breast areaThis therapy went to different process handle any other therapies that were introduced in the past . The Bristol-Myers Squibb , founder of this therapy conducted several(prenominal) therapeutic surveys and studies regarding Ixabepilone . They hav e also conducted an experimentation that would determine the legalness of the therapy to 49 patients within a authentic area of the domain . Through this investigation and experiment , they go far up into a significant result that would help breast cancer patients to count on this therapy as a replenishment to the usual chemotherapyIn 49 patients with taxane-resistant metastatic breast cancer , 12 partially responded to treatment with ixabepilone . Among responders in this study , median reply duration was 10 .4 months median time to progression was 2 .2 months and median pick 7 .9 months . Ixabepilone also proved effective in a study of 23 taxane-napve patients with metastatic breast cancer , where 57 achieved a partial response and 26 stable disease while on ixabepilone therapyThe Antiretroviral TherapyUntil now , many patients of HIV /AIDS are...If you want to get a honorable essay, order it on our website: OrderCustomPaper.com< br/>
If you want to get a full essay, visit our p! age: write my paper